Yazhe Liu

Since joining Kirkland & Ellis, Yazhe represented clients in the following selected transactions:

Capital Markets

• The underwriters in the US$400 million IPO and listing of JHBP (CY) Holdings (HKSE: 6998), a holding company for Genor Biopharma, a commercial-ready biopharmaceutical company that focuses on developing and commercializing oncology and autoimmune drugs
• The underwriters in the US$586.5 million initial public offering and listing on the Nasdaq Global Select Market of Kingsoft Cloud Holdings Limited, one of China’s top cloud services providers
• CMGE Technology Group Limited, a leading IP-based game operator and publisher in China, in its US$191 million initial public offering and listing on the Hong Kong Stock Exchange

Prior to joining Kirkland & Ellis, Yazhe represented clients in the following selected transactions:

Capital Markets

• Tencent Holdings Limited in its spin-off of China Literature Limited by way of a US$919.2 million IPO and separate listing of China Literature Limited on the Hong Kong Stock Exchange
• Yihai International Holding Ltd. (sole supplier of hot pot soup flavoring products to Haidilao) in its US$111 million global offering and listing on the Hong Kong Stock Exchange
• Red Star Macalline Group Corporation Ltd. in its US$931 million global offering and listing on the Hong Kong Stock Exchange
• The underwriters in the US$415 million global offering and listing of Baoxin Auto Group Limited on the Hong Kong Stock Exchange
• Morgan Stanley and Nomura in the US$1.35 billion global offering and listing of Chongqing Rural Commercial Bank Co., Ltd. on the Hong Kong Stock Exchange
• Haitong International Securities Group Limited in a loan capitalization issue to its controlling shareholder and the subsequent offer for sale of capitalization shares by the controlling shareholder
• SinoMedia Holding Limited in its global offering and listing on the Hong Kong Stock Exchange
• Shandong Molong Petroleum Machinery Company Limited on its migration from GEM to the Main Board of the Hong Kong Stock Exchange

M&A/Pre-IPO Investment

• Aluminum Corporation of China Limited in its US$326 million privatization of Chinalco Mining Corporation International
• Sinopharm Group Hongkong Co., Limited, a wholly owned subsidiary of China National Pharmaceutical Group Corporation, in its US$332 million voluntary conditional cash offer for and takeover of Winteam Pharmaceutical Group Limited on the Hong Kong Stock Exchange
• Yihai International Holding Ltd. in its pre-IPO investments by Yunfeng Fund, Greenwoods Bloom Fund and New Hope Agriculture and Food Fund
• SinoMedia Holding Limited in its pre-IPO series A shares financing with Bain Capital as the investor
• A leading commercial banking group in Hong Kong in its proposed sale of shares in VISA and MasterCard
• A leading worldwide express delivery company in its proposed acquisition of certain domestic express delivery business in Mainland China, Hong Kong and Taiwan

Listed Issuers’ Compliance

• PetroChina Company Limited, Hainan Meilan International Airport, Weiqiao Textile Company Limited on corporate governance and continuing obligations under the Hong Kong Listing Rules

Davis Polk & Wardwell

Securities and Futures Commission, Corporate Finance Division

Clifford Chance

Orrick, Herrington & Sutcliffe LLP